+Follow
Eyes Closed
No personal profile
0
Follow
2
Followers
0
Topic
0
Badge
Posts
Hot
Eyes Closed
2022-01-12
$SINGAPORE AIRLINES LTD(C6L.SI)$
In for the long haul
Eyes Closed
2022-02-08
But for how long will all these truly last...
U.S. funding to now cover study of Novavax's COVID-19 shot in adolescents
Eyes Closed
2022-02-10
Gains for now...
Sorry, the original content has been removed
Eyes Closed
2022-02-09
$NIO Inc.(NIO)$
Up for now... then nearer to March? I wonder...
Eyes Closed
2022-01-27
2 days... close it and take profit.
Go to Tiger App to see more news
Invest in Global Markets with Tiger Brokers!
Open App
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4104823715193190","uuid":"4104823715193190","gmtCreate":1641720646696,"gmtModify":1661494436456,"name":"Eyes Closed","pinyin":"eyesclosedeyesclosed","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":0,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.06","exceedPercentage":"60.03%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9096765153,"gmtCreate":1644464557490,"gmtModify":1676533930163,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"Gains for now...","listText":"Gains for now...","text":"Gains for now...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9096765153","repostId":"2210563984","repostType":4,"isVote":1,"tweetType":1,"viewCount":1002,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9096288059,"gmtCreate":1644399512457,"gmtModify":1676533921178,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$</a>Up for now... then nearer to March? I wonder...","listText":"<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$</a>Up for now... then nearer to March? I wonder...","text":"$NIO Inc.(NIO)$Up for now... then nearer to March? I wonder...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9096288059","isVote":1,"tweetType":1,"viewCount":812,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9096363342,"gmtCreate":1644307580680,"gmtModify":1676533910899,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"But for how long will all these truly last...","listText":"But for how long will all these truly last...","text":"But for how long will all these truly last...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9096363342","repostId":"2209905308","repostType":4,"isVote":1,"tweetType":1,"viewCount":1116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9099394051,"gmtCreate":1643295200558,"gmtModify":1676533799465,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"2 days... close it and take profit.","listText":"2 days... close it and take profit.","text":"2 days... close it and take profit.","images":[{"img":"https://static.itradeup.com/news/8941cc8b78ef10f41eb208a750996eb5","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099394051","isVote":1,"tweetType":1,"viewCount":964,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9002853462,"gmtCreate":1641971665250,"gmtModify":1676533667851,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>In for the long haul","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>In for the long haul","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$In for the long haul","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9002853462","isVote":1,"tweetType":1,"viewCount":1523,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9002853462,"gmtCreate":1641971665250,"gmtModify":1676533667851,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>In for the long haul","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>In for the long haul","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$In for the long haul","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9002853462","isVote":1,"tweetType":1,"viewCount":1523,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9096363342,"gmtCreate":1644307580680,"gmtModify":1676533910899,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"But for how long will all these truly last...","listText":"But for how long will all these truly last...","text":"But for how long will all these truly last...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9096363342","repostId":"2209905308","repostType":4,"repost":{"id":"2209905308","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1644290884,"share":"https://ttm.financial/m/news/2209905308?lang=&edition=full_marsco","pubTime":"2022-02-08 11:28","market":"us","language":"en","title":"U.S. funding to now cover study of Novavax's COVID-19 shot in adolescents","url":"https://stock-news.laohu8.com/highlight/detail?id=2209905308","media":"Reuters","summary":"Feb 7 (Reuters) - Novavax Inc(said on Monday U.S. government funding for its COVID-19 vaccine had be","content":"<html><head></head><body><p>Feb 7 (Reuters) - Novavax Inc(said on Monday U.S. government funding for its COVID-19 vaccine had been expanded to cover a late-stage study in adolescents with a booster component.</p><p>Novavax in July 2020 had received $1.6 billion in funding to develop its protein-based vaccine under a government program aimed at accelerating access to coronavirus vaccines and treatments, formerly called Operation Warp Speed.</p><p>The company late last month filed for emergency use authorization of the vaccine for U.S. adults, a long-awaited step following months of struggles with development and manufacturing problems.</p><p>Novavax's two-dose shot has received authorizations from the European Union and the World Health Organization and was recently cleared for use in adults in Britain and New Zealand.</p><p>Novavax last year started testing its vaccine in adolescents aged 12 to 17.</p><p>Currently, rival Pfizer and its partner BioNTech's COVID-19 vaccine is the only one cleared for individuals in that age group in the United States. The U.S. Food and Drug Administration in January also authorized a booster shot of the companies' vaccine for those 12 years and older.</p><p>Novavax in December said receiving an additional booster dose of its vaccine further increased people's immune response to Omicron. The company cited data from ongoing studies of its vaccine's effectiveness in adolescents and as a booster.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. funding to now cover study of Novavax's COVID-19 shot in adolescents</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. funding to now cover study of Novavax's COVID-19 shot in adolescents\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-02-08 11:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Feb 7 (Reuters) - Novavax Inc(said on Monday U.S. government funding for its COVID-19 vaccine had been expanded to cover a late-stage study in adolescents with a booster component.</p><p>Novavax in July 2020 had received $1.6 billion in funding to develop its protein-based vaccine under a government program aimed at accelerating access to coronavirus vaccines and treatments, formerly called Operation Warp Speed.</p><p>The company late last month filed for emergency use authorization of the vaccine for U.S. adults, a long-awaited step following months of struggles with development and manufacturing problems.</p><p>Novavax's two-dose shot has received authorizations from the European Union and the World Health Organization and was recently cleared for use in adults in Britain and New Zealand.</p><p>Novavax last year started testing its vaccine in adolescents aged 12 to 17.</p><p>Currently, rival Pfizer and its partner BioNTech's COVID-19 vaccine is the only one cleared for individuals in that age group in the United States. The U.S. Food and Drug Administration in January also authorized a booster shot of the companies' vaccine for those 12 years and older.</p><p>Novavax in December said receiving an additional booster dose of its vaccine further increased people's immune response to Omicron. The company cited data from ongoing studies of its vaccine's effectiveness in adolescents and as a booster.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2209905308","content_text":"Feb 7 (Reuters) - Novavax Inc(said on Monday U.S. government funding for its COVID-19 vaccine had been expanded to cover a late-stage study in adolescents with a booster component.Novavax in July 2020 had received $1.6 billion in funding to develop its protein-based vaccine under a government program aimed at accelerating access to coronavirus vaccines and treatments, formerly called Operation Warp Speed.The company late last month filed for emergency use authorization of the vaccine for U.S. adults, a long-awaited step following months of struggles with development and manufacturing problems.Novavax's two-dose shot has received authorizations from the European Union and the World Health Organization and was recently cleared for use in adults in Britain and New Zealand.Novavax last year started testing its vaccine in adolescents aged 12 to 17.Currently, rival Pfizer and its partner BioNTech's COVID-19 vaccine is the only one cleared for individuals in that age group in the United States. The U.S. Food and Drug Administration in January also authorized a booster shot of the companies' vaccine for those 12 years and older.Novavax in December said receiving an additional booster dose of its vaccine further increased people's immune response to Omicron. The company cited data from ongoing studies of its vaccine's effectiveness in adolescents and as a booster.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9096765153,"gmtCreate":1644464557490,"gmtModify":1676533930163,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"Gains for now...","listText":"Gains for now...","text":"Gains for now...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9096765153","repostId":"2210563984","repostType":4,"isVote":1,"tweetType":1,"viewCount":1002,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9096288059,"gmtCreate":1644399512457,"gmtModify":1676533921178,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$</a>Up for now... then nearer to March? I wonder...","listText":"<a href=\"https://ttm.financial/S/NIO\">$NIO Inc.(NIO)$</a>Up for now... then nearer to March? I wonder...","text":"$NIO Inc.(NIO)$Up for now... then nearer to March? I wonder...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9096288059","isVote":1,"tweetType":1,"viewCount":812,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9099394051,"gmtCreate":1643295200558,"gmtModify":1676533799465,"author":{"id":"4104823715193190","authorId":"4104823715193190","name":"Eyes Closed","avatar":"https://community-static.tradeup.com/news/e8cb4318cb1bee321ad47bb2b5ee1403","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4104823715193190","authorIdStr":"4104823715193190"},"themes":[],"htmlText":"2 days... close it and take profit.","listText":"2 days... close it and take profit.","text":"2 days... close it and take profit.","images":[{"img":"https://static.itradeup.com/news/8941cc8b78ef10f41eb208a750996eb5","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099394051","isVote":1,"tweetType":1,"viewCount":964,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}